Unusual Soft Tissue Uptake of F-18 Sodium Fluoride in Three Patients Undergoing F-18 NaF PET/CT Bone Scans for Prostate Cancer

Overview

Journal Nucl Med Mol Imaging

Publisher Springer

Date 2017 Sep 8

PMID 28878857

Authors

Andrew S Hawkins

Brandon A Howard

Affiliations

Soon will be listed here.

Abstract

Three males aged 71 to 80 years with known stage IV metastatic prostate cancer underwent F-18 sodium fluoride (NaF) PET/CT to assess osseous metastatic disease burden and stability. In addition to F-18 NaF avid known osseous metastases, each patient also exhibited increased F-18 NaF activity in soft tissues. The first patient exhibited multiple F-18 NaF avid enlarged retroperitoneal and pelvic lymph nodes on consecutive PET/CT scans. The second patient demonstrated an F-18 NaF avid thyroid nodule on consecutive PET/CT scans. The third patient exhibited increased F-18 NaF activity in a hepatic metastasis.

References

Basu S, Kembhavi S . Serendipitous observation of hepatic metastases on (18)F-fluoride PET in a patient with infiltrating ductal carcinoma of breast: correlation with contrast enhanced CT. Clin Nucl Med. 2012; 37(12):1176-8. DOI: 10.1097/RLU.0b013e318270820a. View

Swietaszczyk C, Prasad V, Baum R . Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapy. Clin Nucl Med. 2012; 37(4):e82-3. DOI: 10.1097/RLU.0b013e3182478a50. View

Kurdziel K, Shih J, Apolo A, Lindenberg L, Mena E, McKinney Y . The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med. 2012; 53(8):1175-84. PMC: 3474293. DOI: 10.2967/jnumed.111.100883. View

Sabbah N, Jackson T, Mosci C, Jamali M, Minamimoto R, Quon A . 18F-sodium fluoride PET/CT in oncology: an atlas of SUVs. Clin Nucl Med. 2014; 40(4):e228-31. DOI: 10.1097/RLU.0000000000000633. View

Hawkins R, Choi Y, Huang S, Hoh C, Dahlbom M, Schiepers C . Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med. 1992; 33(5):633-42. View

Chun A, Jo H, Lee S, Chun H, Park J, Kim K . Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Endocrinol Metab (Seoul). 2014; 30(1):71-7. PMC: 4384680. DOI: 10.3803/EnM.2015.30.1.71. View

Valdes-Martinez A, Kraft S, Brundage C, Arceneaux B, Stewart J, Gibbons D . Assessment of blood pool, soft tissue, and skeletal uptake of sodium fluoride F 18 with positron emission tomography-computed tomography in four clinically normal dogs. Am J Vet Res. 2012; 73(10):1589-95. DOI: 10.2460/ajvr.73.10.1589. View

Sheth S, Colletti P . Atlas of sodium fluoride PET bone scans: atlas of NaF PET bone scans. Clin Nucl Med. 2012; 37(5):e110-6. DOI: 10.1097/RLU.0b013e31824c81ee. View

Yoon D, Chang S, Choi C, Yun E, Seo Y, Nam E . The prevalence and significance of incidental thyroid nodules identified on computed tomography. J Comput Assist Tomogr. 2008; 32(5):810-5. DOI: 10.1097/RCT.0b013e318157fd38. View

10.

Shie P, Cardarelli R, Sprawls K, Fulda K, Taur A . Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 2009; 30(9):742-8. DOI: 10.1097/MNM.0b013e32832ee09d. View

11.

Cook G, Fogelman I . The role of positron emission tomography in skeletal disease. Semin Nucl Med. 2001; 31(1):50-61. DOI: 10.1053/snuc.2001.18746. View

12.

Segall G, Delbeke D, Stabin M, Even-Sapir E, Fair J, Sajdak R . SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med. 2010; 51(11):1813-20. DOI: 10.2967/jnumed.110.082263. View

13.

Wong K, Piert M . Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications. J Nucl Med. 2013; 54(4):590-9. DOI: 10.2967/jnumed.112.114298. View

14.

Dweck M, Chow M, Joshi N, Williams M, Jones C, Fletcher A . Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012; 59(17):1539-48. DOI: 10.1016/j.jacc.2011.12.037. View